These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 31121064)

  • 1. Age at diagnosis is an important prognostic factor in Philadelphia-negative Myeloproliferative Neoplasms.
    Accurso V; Santoro M; Siragusa S
    Eur J Haematol; 2019 Aug; 103(2):140-141. PubMed ID: 31121064
    [No Abstract]   [Full Text] [Related]  

  • 2. Incidence of chronic Philadelphia chromosome negative (Ph-) myeloproliferative disorders in the Côte d'Or area, France, during 1980-99.
    Girodon F; Jooste V; Maynadie M; Favre B; Schaeffer C; Carli P
    J Intern Med; 2005 Jul; 258(1):90-1. PubMed ID: 15953137
    [No Abstract]   [Full Text] [Related]  

  • 3. Patient characteristics and outcomes in adolescents and young adults with classical Philadelphia chromosome-negative myeloproliferative neoplasms.
    Boddu P; Masarova L; Verstovsek S; Strati P; Kantarjian H; Cortes J; Estrov Z; Pierce S; Pemmaraju N
    Ann Hematol; 2018 Jan; 97(1):109-121. PubMed ID: 29143068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Classification of Philadelphia translocation-negative myeloproliferative neoplasms: its impact on data from clinical trials.
    Naresh KN
    J Clin Oncol; 2009 Nov; 27(31):e175-6; author reply e177-8. PubMed ID: 19704052
    [No Abstract]   [Full Text] [Related]  

  • 5. Cytogenetics in the management of Philadelphia-negative myeloproliferative neoplasms: an update by the Groupe francophone de cytogénétique hématologique (GFCH).
    Bilhou-Nabéra C; Bidet A; Eclache V; Lippert E; Mozziconacci MJ
    Ann Biol Clin (Paris); 2016 Oct; 74(5):517-523. PubMed ID: 27477946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular markers guide diagnosis and treatment in Philadelphia chromosome-negative myeloproliferative disorders (Review).
    Vladareanu AM; Müller-Tidow C; Bumbea H; Radesi S
    Oncol Rep; 2010 Mar; 23(3):595-604. PubMed ID: 20126996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Myeloproliferative disorders "Philadelphia negative" and JAK2V617F mutation: study of 15 cases in Togo].
    Padaro E; Agbetiafa K; Delagnon Kueviakoe IM; Layibo Y; Amegbor K; Vovor A; Giraudier S; Sanogo I; Segbena AY
    Ann Biol Clin (Paris); 2012 Oct; 70(5):591-4. PubMed ID: 23047905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dysregulation of shelterin factors coupled with telomere shortening in Philadelphia chromosome negative myeloproliferative neoplasms.
    Dahlström J; Zhang X; Ghaderi M; Hultcrantz M; Björkholm M; Xu D
    Haematologica; 2015 Oct; 100(10):e402-5. PubMed ID: 26185173
    [No Abstract]   [Full Text] [Related]  

  • 9. Reclassification of subtypes in Philadelphia chromosome-negative myeloproliferative neoplasm by 2016 WHO diagnostic criteria: focus on the cases classified as myeloproliferative neoplasm, unclassifiable by the 2008 version.
    Yun J; Kim JA; Park J; Im K; Lee YE; Jeong D; Ryu S; Lim KM; Kim SM; Ahn YO; Lee DS
    Leuk Lymphoma; 2020 Dec; 61(14):3498-3502. PubMed ID: 32876501
    [No Abstract]   [Full Text] [Related]  

  • 10. [Summary of recommendations for the diagnosis and therapy of BCR/ABL-negative myeloproliferation of the Czech Working Group for Ph-negative myeloproliferative disease (CZEMP) of the Czech Hematologic Society CLS JEP ].
    Penka M; Schwarz J; Campr V; Pospíšilová D; Křen L; Nováková L; Bodzásová C; Brychtová Y; Cerná O; Dulíček P; Jonášová A; Kissová J; Kořístek Z; Schützová M; Vonke I; Walterová L;
    Vnitr Lek; 2012 Feb; 58(2):163-8. PubMed ID: 22463098
    [No Abstract]   [Full Text] [Related]  

  • 11. Next-generation sequencing discriminates myelodysplastic/myeloproliferative neoplasms from paraneoplastic leukemoid reaction in cancer patients with hyperleukocytosis.
    Sakr R; Renneville A; Saada V; Cotteret S; Martin JE; Droin N; Selimoglu-Buet D; Besse B; Hollebecque A; Marzac C; Pasquier F; Micol JB; De Botton S; Mir O; Solary E; Willekens C
    Leuk Lymphoma; 2018 Jul; 59(7):1742-1745. PubMed ID: 29115897
    [No Abstract]   [Full Text] [Related]  

  • 12. [Concurrent lymphoid and Philadelphia chromosome-negative myeloproliferative neoplasms].
    Torregrosa JM; Soler G; Cancio S; Ferrer-Marin F
    Med Clin (Barc); 2015 Oct; 145(7):318-9. PubMed ID: 25618739
    [No Abstract]   [Full Text] [Related]  

  • 13. The WHO 2008 classification of Ph-myeloproliferative disorders: statement of the Czech MPD Working Group.
    Schwarz J; Penka M; Indrák K; Pospísilová D; Pytlík R; Dulícek P; Doubek M; Kren L; Campr V;
    Leukemia; 2008 Nov; 22(11):2118-9. PubMed ID: 18418405
    [No Abstract]   [Full Text] [Related]  

  • 14. [Reduction of Ph1 chromosome in atypical myeloproliferative disorder by intensive chemotherapy].
    Takeyama H; Yano K; Fukutani H; Yamamoto F; Watanabe E; Satake T
    Rinsho Ketsueki; 1986 Sep; 27(9):1640-4. PubMed ID: 3468279
    [No Abstract]   [Full Text] [Related]  

  • 15. Molecular markers for the diagnosis of Philadelphia chromosome negative myeloproliferative disorders.
    Klippel S; Pahl HL
    Pathol Biol (Paris); 2004 Jun; 52(5):267-74. PubMed ID: 15217712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of MPL W515L/K mutations in Taiwanese patients with Philadelphia-negative chronic myeloproliferative neoplasms.
    Lieu CH; Shen YJ; Lai WC; Tsai WH; Hsu HC
    J Chin Med Assoc; 2010 Oct; 73(10):530-2. PubMed ID: 21051030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The myeloid disorders: background.
    Swansbury J
    Methods Mol Biol; 2003; 220():23-42. PubMed ID: 12744204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thromboembolism prophylaxis in patients with Philadelphia-negative myeloproliferative neoplasms-Clinical practice among Nordic specialists.
    Bjerrum OW; Samuelsson J; Ghanima W; Kauppila M; Andersen CL;
    Eur J Haematol; 2018 May; 100(5):475-478. PubMed ID: 29427461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Philadelphia chromosome-negative myeloproliferative disorders: an historical perspective.
    Prchal JT
    Hematology Am Soc Hematol Educ Program; 2008; ():68. PubMed ID: 19074060
    [No Abstract]   [Full Text] [Related]  

  • 20. Trisomy 13 in a Philadelphia negative chromosome and BCR-ABL negative myeloproliferative disorder.
    Cabrol C; Samii K; Scherrer A; Darbellay R; Beris P
    Cancer Genet Cytogenet; 1999 Jun; 111(2):184-5. PubMed ID: 10347563
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.